According to the latest data from the Hong Kong Stock Exchange, on December 18, China International Capital Corporation Limited increased its stake in NOVOSENSE (02676) by 67,200 shares at an average price of HK$113.4707 per share, totaling approximately HK$7.6252 million. Following this transaction, the firm's total holdings in NOVOSENSE rose to approximately 3.6703 million shares, representing a 19.24% stake.